Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease.
about
Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.A review of β-amyloid neuroimaging in Alzheimer's disease.Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization.MRI in rodent models of brain disordersUnveiling molecular events in the brain by noninvasive imaging.Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance ImagingQuantitative multimodal multiparametric imaging in Alzheimer's disease.SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid ImmunotherapyDetection of Aβ plaque deposition in MR images based on pixel feature selection and class information in image level.Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.Bioavailable Trace Metals in Neurological Diseases.In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.Development of Cerebral Microbleeds in the APP23-Transgenic Mouse Model of Cerebral Amyloid Angiopathy-A 9.4 Tesla MRI Study.In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component.Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment.Multilayer appearance on contrast-enhanced susceptibility-weighted images on patients with brain abscesses: Possible origins and effects of postprocessing.Usefulness of SWI for the Detection of Iron in the Motor Cortex in Amyotrophic Lateral Sclerosis.Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review
P2860
Q30666219-6C4EE249-7568-4ECE-B891-3C7B72164ECEQ30870063-0F99DB28-DB91-495F-AEF4-338E0A73D933Q31144061-2F17B536-ECB6-4E1D-BB7E-F0D574A021E9Q33806015-CDD475B7-0121-4425-8EE5-1D40486EE009Q34046040-D094096E-31AF-4203-B455-B72B54C1D6A0Q34805022-BFCB0506-6461-4102-BFFD-E453E735B7E4Q36164757-F7FD9F08-E521-493D-A486-3C29777D3D4DQ36710294-F47E5ED0-5A7E-40E6-84F5-4F5D1823A3A7Q36715449-12885CED-28E7-48CE-A9E7-08E050F88A4DQ37260549-20229AF5-4808-432A-B195-990258BDF228Q37866098-B8E1BC78-A94C-427F-8E9A-5B58CD5E2454Q38967236-A1771A54-23CD-4323-AA76-409419F5CD77Q39090644-0EBC6DF9-6567-4B5E-92E2-DE2E75D331E5Q39906670-DB6FED56-461C-4EBE-AA66-9AA00CAE16DAQ41711189-68E1F9E7-128B-4416-B7FC-CA08E054B00EQ42084531-5C56FDE2-13C6-4129-A4D1-C582EDA61691Q42095705-8A3BDDAB-C59D-46E2-A704-C9B9D3B496D4Q42118376-F374F6CE-093D-4079-A42A-40A6E3B7C8DBQ42725476-D60C3E19-AA39-4A12-A820-440840C4BF56Q47998495-98995FB8-E02F-4D99-83E6-01203FCABC73Q48028189-42424597-AD67-43BE-B7B9-C994063C80F2Q48321664-AC15474E-59BC-454B-AB49-D42F3171A43EQ48741515-82F8937E-D5A0-4CB9-B9D1-98ED8FAC24D9Q58722862-96EDB57A-E88F-4325-A898-B383C399016F
P2860
Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@ast
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@en
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@nl
type
label
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@ast
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@en
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@nl
altLabel
Comparison of amyloid plaque c ...... models of Alzheimer's disease
@en
prefLabel
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@ast
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@en
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Comparison of amyloid plaque c ...... models of Alzheimer's disease.
@en
P2093
Denise Reyes
Geoffrey L Curran
Joseph F Poduslo
Malgorzata Marjanska
Michael Garwood
Ryan Chamberlain
Thomas M Wengenack
P2860
P304
P356
10.1002/MRM.21951
P407
P577
2009-05-01T00:00:00Z